This early mechanistic study supports the hypothesis that aspirin inhibits platelet function via acetylation.
Answers are grounded in this paper and cite their sources.
Cautions against clinical extrapolation from animals; extends preclinical support for acetylation-dependent platelet effects.
Aspirin produces alteration of platelet function characterized by loss of secondary aggregation in response to ADP or epinephrine, and inhibition of aggregation by collagen. In addition, platelet factor 3 release by these reagents is reduced. A similar platelet lesion was produced by an acetylating agent, acetic anhydride, supporting earlier concepts that aspirin activity against platelets may be a consequence of acetylation. An attempt to identify specific acetylation of platelets with acetyl-1-14C salicylic acid was unsuccessful. Although platelet uptake of the label was demonstrated, metabolic incorporation of acetate could not be excluded.
No takes yet. Share an insight, caveat, or question.
Al‐Mondhiry et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: